The American College of Cardiology abandoned plans to have an in-person component to its meeting in May.
Bernard Lown, MD — heart defibrillator inventor, pioneer in lifestyle medicine for cardiovascular disease, and peace activist — died at 99 after suffering from congestive heart failure. (AP)
Mechanical thrombectomy appeared to help posterior circulation distal, medium vessel occlusion. (JAMA Neurology)
Quality measures? Meh, say interventional cardiologists. Survey says feedback from case conferences and informal peer interactions are more useful. (American Heart Journal)
After severe COVID-19 with elevated troponin, about a quarter of patients had what looked like myocarditis and about a quarter had infarcts or ischemia. (European Heart Journal)
CT surveillance of abdominal aortic aneurysms smaller than 4.25 cm can be safely pushed to at least 2 years, analysis of randomized trial data suggested. (JAMA Surgery)
More good news on PCSK9 gene editing: 3-year cholesterol data in monkeys look promising. (Endpoints News)
Medtronic is recalling its Valiant Navion TEVAR stent grafts after three patients in a trial had stent fractures, including two confirmed type IIIb endoleaks, and one patient died.
FDA announced a class I recall of Boston Scientific’s Emblem subcutaneous implantable cardioverter-defibrillator over a manufacturing issue that can cause a short circuit when it goes to deliver a shock.
Even a little air pollution for a long time damages the heart, researchers reported in Circulation.
An actual next-gen wearable: a small stick-on patch can measure blood pressure and heart rate, as well as lactate, caffeine, and alcohol in sweat and glucose in interstitial fluid — although there are still some kinks to work out. (Nature)